APPLICATIONS PUBLISHED 3 NOVEMBER 2004

Published: 2-Jun-2005

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Process for preparing water-soluble phosphono-oxymethyl derivatives of alcohol and phenol
    Guilford Pharmaceuticals 1471920*

  • Counteracting bioprosthetic calcification
    The Children's Hospital of Philadelphia 1471921*

  • Methods and materials for modulating task-3
    Algos Therapeutics 1471922*

  • Amido macrolides
    Kosan Biosciences 1471923*

  • Idraparinux (Sanorg 34006) for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis
    Akzo Nobel 1471924*

  • Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compsns
    Alcon 1471925*

  • Compsns and methods for the therapeutic use of an atonal-associated sequence
    Baylor College of Medicine 1471926*

  • Diagnostics and therapeutics for diseases associated with neuromedin U1 receptor (NMU1)
    Bayer 1471927*

  • HIV inhibiting proteins
    Delta Biotechnology 1471928*

  • Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
    Academisch Ziekenhuuis Leiden 1471929*

  • Use of erythropoietin for the preventative or curative treatment of cardiac failure
    Crucell Holland 1471930*

  • Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compsns and kits relating thereto
    Maine Medical Centre Research Institute 1471931*

  • Use of a polypeptide for treatment of pruritis in animals
    Zengen 1471932*

  • Albumin-fused anti-angiogenesis peptides
    Delta Biotechnology 1471933*

  • Kinases involved in the regulation of energy homeostasis
    Developgen Aktiengesellschaft fuer Entwicklungsbiologischeforschung 1471934*

  • Protease screening and novel use of proteases
    N-Zyme BioTec 1471935*

  • HIV vaccine and method of use
    Chiron Corp 1471936*

  • A continuous cell line for the production of vaccines
    Lohmann Animal Health 1471937*

  • Human monoclonal antibodies against CD30
    Medarex 1471938*

  • Delivery of neutron capture elements for neuron capture therapy
    Psimel Pharmaceuticals 1471939*

  • Inactivation of the West Nile virus and Plasmodium falciparum using alloxazine-derivating photosensitisers
    Gambro 1471941*

  • Immunocytokine-containing lyophilised preparation
    Merck Patent 1471942*

  • Conjugate for treating prokaryotic infections
    Deutsches Krebsforschungszentrum Stiftung des oefflentichen Rechts 1471943*

  • Pharmaceutical compsn which improves in vivo gene transfer
    Institut National de la Sante et de la Recheche Medicale 1471944*

  • You may also like